New chemistry reduces barriers to scaling single-cell studies across research settingsLaunch planned for March 2026, available across Evercode Whole Transcriptome product lineSEATTLE, Wash. & VENLO, ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results